Crowson, C. S. et al. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann. Rheum. Dis. 77, 48–54 (2018).
Safiri, S. et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann. Rheum. Dis. 78, 1463–1471 (2019).
Fu, J. et al. Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis. Proc. Natl. Acad. Sci. USA 115, 4755–4760 (2018).
Ospelt, C. et al. Epigenetics in the pathogenesis of RA. Semin Immunopathol. 39, 409–419 (2017).
McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).
Scott, D. L. et al. Rheumatoid arthritis. Lancet 376, 1094–1108 (2010).
McInnes, I. B. & Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389, 2328–2337 (2017).
Lee, R. C. et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854 (1993).
Bushati, N. & Cohen, S. M. microRNA functions. Annu Rev. Cell Dev. Biol. 23, 175–205 (2007).
Lee, Y. S. & Dutta, A. MicroRNAs in cancer. Annu Rev. Pathol. 4, 199–227 (2009).
Zhou, S. S. et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharm. Sin. 39, 1073–1084 (2018).
Ali, S. A. et al. The non-coding RNA interactome in joint health and disease. Nat. Rev. Rheumatol. 17, 692–705 (2021).
Dakin, S. G. et al. Pathogenic stromal cells as therapeutic targets in joint inflammation. Nat. Rev. Rheumatol. 14, 714–726 (2018).
Aletaha, D. & Smolen, J. S. Diagnosis and management of rheumatoid arthritis: a review. JAMA 320, 1360–1372 (2018).
Bottini, N. & Firestein, G. S. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9, 24–33 (2012).
Mousavi, M. J. et al. Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe. Auto. Immun. Highlights 12, 3 (2021).
Firestein, G. S. et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA 94, 10895–10900 (1997).
Tu, J. et al. A Tale of Two Immune Cells in Rheumatoid Arthritis: The Crosstalk Between Macrophages and T Cells in the Synovium. Front. Immunol. 12, 655477 (2021).
Kondo, Y. et al. Review: Transcriptional Regulation of CD4+ T Cell Differentiation in Experimentally Induced Arthritis and Rheumatoid Arthritis. Arthritis Rheumatol. 70, 653–661 (2018).
Niu, Q. et al. Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol. Int. 32, 2731–2736 (2012).
Wehrens, E. J. et al. T cells out of control-impaired immune regulation in the inflamed joint. Nat. Rev. Rheumatol. 9, 34–42 (2013).
Wu, F. et al. B Cells in Rheumatoid ArthritisPathogenic Mechanisms and Treatment Prospects. Front. Immunol. 12, 750753 (2021).
Ronnelid, J. et al. Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives. Front. Immunol. 12, 685312 (2021).
Kennedy, A. et al. Macrophages in synovial inflammation. Front. Immunol. 2, 52 (2011).
Hannemann, N. et al. New insights into macrophage heterogeneity in rheumatoid arthritis. Jt. Bone Spine 88, 105091 (2021).
Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792–804 (2013).
Lavin, Y. et al. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 15, 731–744 (2015).
Huang, Q.-Q. et al. Critical role of synovial tissue-resident macrophage niche in joint homeostasis and suppression of chronic inflammation. Sci. Adv. 7, eabd0515 (2021).
Das, A. et al. Monocyte and macrophage plasticity in tissue repair and regeneration. Am. J. Pathol. 185, 2596–2606 (2015).
Funes, S. C. et al. Implications of macrophage polarization in autoimmunity. Immunology 154, 186–195 (2018).
Wang, Y. et al. Is macrophage polarization important in rheumatoid arthritis? Int. Immunopharmacol. 50, 345–352 (2017).
Cascao, R. et al. Neutrophils in rheumatoid arthritis: More than simple final effectors. Autoimmun. Rev. 9, 531–535 (2010).
Iberg, C. A. et al. Dendritic cells as inducers of peripheral tolerance. Trends Immunol. 38, 793–804 (2017).
Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343–353 (2015).
Schett, G. & Gravallese, E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheumatol. 8, 656–664 (2012).
Asagiri, M. & Takayanagi, H. The molecular understanding of osteoclast differentiation. Bone 40, 251–264 (2007).
Wada, T. et al. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17–25 (2006).
Amarasekara, D. S. et al. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 18, e8 (2018).
Hashizume, M. et al. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatol. (Oxf.) 47, 1635–1640 (2008).
Baum, R. & Gravallese, E. M. Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts. Clin. Rev. Allergy Immunol. 51, 1–15 (2016).
Otero, M. & Goldring, M. B. Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res. Ther. 9, 220 (2007).
Li, Z. et al. Omentin-1 prevents cartilage matrix destruction by regulating matrix metalloproteinases. Biomed. Pharmacother. 92, 265–269 (2017).
Goldring, M. B. & Marcu, K. B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 11, 224 (2009).
Falconer, J. et al. Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol. 70, 984–999 (2018).
Elshabrawy, H. A. et al. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 18, 433–448 (2015).
Laurent, L. et al. Fcgamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann. Rheum. Dis. 70, 1052–1059 (2011).
Negishi-Koga, T. et al. Immune complexes regulate bone metabolism through FcRgamma signalling. Nat. Commun. 6, 6637 (2015).
Bartok, B. & Firestein, G. S. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233–255 (2010).
Bottini, N. & Firestein, G. S. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9, 24–33 (2013).
留言 (0)